RRP9 promotes prostate cancer metastasis and epithelial-mesenchymal transition through activation of the AKT/GSK3β/β-Catenin signaling pathway

Abstract Ribosomal RNA Processing 9 (RRP9) is a gene associated with ribosomal function, and studies have demonstrated that its expression is aberrantly regulated in various tumor types, correlating with tumor progression. However, the specific role and underlying mechanism of RRP9 in prostate cance...

Full description

Saved in:
Bibliographic Details
Main Authors: Zijian Da, Yadan Du, Yawen Chen, Mingxu Da, Fenghai Zhou
Format: Article
Language:English
Published: Springer 2025-06-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-02833-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850114581788098560
author Zijian Da
Yadan Du
Yawen Chen
Mingxu Da
Fenghai Zhou
author_facet Zijian Da
Yadan Du
Yawen Chen
Mingxu Da
Fenghai Zhou
author_sort Zijian Da
collection DOAJ
description Abstract Ribosomal RNA Processing 9 (RRP9) is a gene associated with ribosomal function, and studies have demonstrated that its expression is aberrantly regulated in various tumor types, correlating with tumor progression. However, the specific role and underlying mechanism of RRP9 in prostate cancer (PCa) remain largely unexplored. In this study, bioinformatics analysis revealed that RRP9 is upregulated in PCa and is significantly associated with poor prognosis and lymph node metastasis. Further experimental data demonstrated that RRP9 knockdown notably inhibited the metastasis, invasion, and epithelial-mesenchymal transition (EMT) of PCa. Conversely, overexpression of RRP9 activated the AKT signaling pathway, resulting in the phosphorylation of GSK3β at Ser9, which in turn prevented β-catenin degradation and promoted cell metastasis, invasion, and EMT. Rescue experiments demonstrated that SC79 effectively reversed the inhibitory effects of RRP9 knockdown on PCa. These findings highlight the potential role of RRP9 in promoting the malignant biological behaviors of PCa, providing new insights and potential therapeutic strategies for the treatment of the disease.
format Article
id doaj-art-4b4084d557c94c70a2ef975d035b2075
institution OA Journals
issn 2730-6011
language English
publishDate 2025-06-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj-art-4b4084d557c94c70a2ef975d035b20752025-08-20T02:36:50ZengSpringerDiscover Oncology2730-60112025-06-0116111310.1007/s12672-025-02833-4RRP9 promotes prostate cancer metastasis and epithelial-mesenchymal transition through activation of the AKT/GSK3β/β-Catenin signaling pathwayZijian Da0Yadan Du1Yawen Chen2Mingxu Da3Fenghai Zhou4The First School of Clinical Medicine, Lanzhou UniversityThe First Clinical College, Gansu University of Traditional Chinese MedicineThe First Clinical College, Gansu University of Traditional Chinese MedicineThe First School of Clinical Medicine, Lanzhou UniversityThe First School of Clinical Medicine, Lanzhou UniversityAbstract Ribosomal RNA Processing 9 (RRP9) is a gene associated with ribosomal function, and studies have demonstrated that its expression is aberrantly regulated in various tumor types, correlating with tumor progression. However, the specific role and underlying mechanism of RRP9 in prostate cancer (PCa) remain largely unexplored. In this study, bioinformatics analysis revealed that RRP9 is upregulated in PCa and is significantly associated with poor prognosis and lymph node metastasis. Further experimental data demonstrated that RRP9 knockdown notably inhibited the metastasis, invasion, and epithelial-mesenchymal transition (EMT) of PCa. Conversely, overexpression of RRP9 activated the AKT signaling pathway, resulting in the phosphorylation of GSK3β at Ser9, which in turn prevented β-catenin degradation and promoted cell metastasis, invasion, and EMT. Rescue experiments demonstrated that SC79 effectively reversed the inhibitory effects of RRP9 knockdown on PCa. These findings highlight the potential role of RRP9 in promoting the malignant biological behaviors of PCa, providing new insights and potential therapeutic strategies for the treatment of the disease.https://doi.org/10.1007/s12672-025-02833-4RRP9AKTGSK3ββ-cateninProstate cancerMetastasis
spellingShingle Zijian Da
Yadan Du
Yawen Chen
Mingxu Da
Fenghai Zhou
RRP9 promotes prostate cancer metastasis and epithelial-mesenchymal transition through activation of the AKT/GSK3β/β-Catenin signaling pathway
Discover Oncology
RRP9
AKT
GSK3β
β-catenin
Prostate cancer
Metastasis
title RRP9 promotes prostate cancer metastasis and epithelial-mesenchymal transition through activation of the AKT/GSK3β/β-Catenin signaling pathway
title_full RRP9 promotes prostate cancer metastasis and epithelial-mesenchymal transition through activation of the AKT/GSK3β/β-Catenin signaling pathway
title_fullStr RRP9 promotes prostate cancer metastasis and epithelial-mesenchymal transition through activation of the AKT/GSK3β/β-Catenin signaling pathway
title_full_unstemmed RRP9 promotes prostate cancer metastasis and epithelial-mesenchymal transition through activation of the AKT/GSK3β/β-Catenin signaling pathway
title_short RRP9 promotes prostate cancer metastasis and epithelial-mesenchymal transition through activation of the AKT/GSK3β/β-Catenin signaling pathway
title_sort rrp9 promotes prostate cancer metastasis and epithelial mesenchymal transition through activation of the akt gsk3β β catenin signaling pathway
topic RRP9
AKT
GSK3β
β-catenin
Prostate cancer
Metastasis
url https://doi.org/10.1007/s12672-025-02833-4
work_keys_str_mv AT zijianda rrp9promotesprostatecancermetastasisandepithelialmesenchymaltransitionthroughactivationoftheaktgsk3bbcateninsignalingpathway
AT yadandu rrp9promotesprostatecancermetastasisandepithelialmesenchymaltransitionthroughactivationoftheaktgsk3bbcateninsignalingpathway
AT yawenchen rrp9promotesprostatecancermetastasisandepithelialmesenchymaltransitionthroughactivationoftheaktgsk3bbcateninsignalingpathway
AT mingxuda rrp9promotesprostatecancermetastasisandepithelialmesenchymaltransitionthroughactivationoftheaktgsk3bbcateninsignalingpathway
AT fenghaizhou rrp9promotesprostatecancermetastasisandepithelialmesenchymaltransitionthroughactivationoftheaktgsk3bbcateninsignalingpathway